Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Si-Bone (SIBN) Capital Expenditures (2017 - 2025)

Si-Bone has reported Capital Expenditures over the past 9 years, most recently at $1.3 million for Q4 2025.

  • Quarterly results put Capital Expenditures at $1.3 million for Q4 2025, down 43.16% from a year ago — trailing twelve months through Dec 2025 was $8.4 million (down 19.84% YoY), and the annual figure for FY2025 was $8.4 million, down 19.84%.
  • Capital Expenditures for Q4 2025 was $1.3 million at Si-Bone, down from $6.1 million in the prior quarter.
  • Over the last five years, Capital Expenditures for SIBN hit a ceiling of $6.3 million in Q3 2022 and a floor of -$3.7 million in Q3 2021.
  • Median Capital Expenditures over the past 5 years was $1.5 million (2022), compared with a mean of $2.1 million.
  • Peak annual rise in Capital Expenditures hit 3121.51% in 2021, while the deepest fall reached 332.46% in 2021.
  • Si-Bone's Capital Expenditures stood at $5.9 million in 2021, then tumbled by 71.94% to $1.7 million in 2022, then plummeted by 34.16% to $1.1 million in 2023, then skyrocketed by 107.32% to $2.3 million in 2024, then plummeted by 43.16% to $1.3 million in 2025.
  • The last three reported values for Capital Expenditures were $1.3 million (Q4 2025), $6.1 million (Q3 2025), and -$1.1 million (Q2 2025) per Business Quant data.